Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 4:55 pm Purchase | 2023-12-31 | 13G | KIORA PHARMACEUTICALS INC KPRX | Lincoln Park Capital Fund LLC | 260,731 9.990% | 251,619 (+2761.40%) | Filing History |
| 2024-02-14 4:32 pm Sale | 2023-12-31 | 13G | X4 PHARMACEUTICALS INC XFOR | Lincoln Park Capital Fund LLC | 53,338 0.947% | -6,998 (-11.60%) | Filing History |
| 2024-02-14 4:31 pm Sale | 2023-12-31 | 13G | TRACON PHARMACEUTICALS INC TCON | Lincoln Park Capital Fund LLC | 5,841 0.375% | -112,650 (-95.07%) | Filing History |
| 2024-02-14 4:31 pm Sale | 2023-12-31 | 13G | ENSYSCE BIOSCIENCES INC NE ENSC | Lincoln Park Capital Fund LLC | 8,267 3.792% | -72 (-0.86%) | Filing History |
| 2024-02-14 4:30 pm Sale | 2023-12-31 | 13G | WINDTREE THERAPEUTIC WINT | Lincoln Park Capital Fund LLC | 377 6.181% | -133 (-26.08%) | Filing History |
| 2024-02-14 4:29 pm Purchase | 2023-12-31 | 13G | CELLECTAR BIOSCIENCES INC CLRB | Lincoln Park Capital Fund LLC | 43,568 9.676% | 12,315 (+39.40%) | Filing History |
| 2023-06-02 4:46 pm Purchase | 2023-05-31 | 13G | TRACON PHARMACEUTICALS INC TCON | Lincoln Park Capital Fund LLC | 118,491 8.980% | 118,491 (New Position) | Filing History |
| 2023-04-24 4:33 pm Purchase | 2023-04-20 | 13G | WINDTREE THERAPEUTIC WINT | Lincoln Park Capital Fund LLC | 510 9.990% | 510 (New Position) | Filing History |
| 2023-02-06 6:34 pm Purchase | 2023-02-02 | 13G | ENSYSCE BIOSCIENCES INC NE ENSC | Lincoln Park Capital Fund LLC | 8,339 9.990% | 8,339 (New Position) | Filing History |
| 2022-10-25 06:01 am Purchase | 2022-10-21 | 13G | CELLECTAR BIOSCIENCES INC CLRB | Lincoln Park Capital Fund LLC | 31,253 9.990% | 23,541 (+305.25%) | Filing History |
| 2022-07-28 5:09 pm Purchase | 2022-07-26 | 13G | KIORA PHARMACEUTICALS INC KPRX | Lincoln Park Capital Fund LLC | 9,112 9.990% | 9,112 (New Position) | Filing History |
| 2022-05-18 12:34 pm Purchase | 2022-05-17 | 13G | VALLON PHARMACEUTICALS INC VLON | Lincoln Park Capital Fund LLC | 35,008 9.990% | 35,008 (New Position) | Filing History |
| 2022-04-27 10:52 am Purchase | 2022-04-22 | 13G | SALARIUS PHARMACEUTICALS INC SLRX | Lincoln Park Capital Fund LLC | 990 5.980% | 990 (New Position) | Filing History |
| 2022-01-19 11:05 am Purchase | 2022-01-14 | 13G | X4 PHARMACEUTICALS INC XFOR | Lincoln Park Capital Fund LLC | 60,336 6.440% | 60,336 (New Position) | Filing History |
| 2021-11-19 12:57 pm Purchase | 2021-11-12 | 13G | NABRIVA THERAPEUTICS AG NBRV | Lincoln Park Capital Fund LLC | 180,504 7.960% | 180,504 (New Position) | Filing History |